이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

InnovAge Holding 관리

관리 기준 확인 3/4

InnovAge Holding's CEO는 Patrick Blair, Dec2021 에 임명되었습니다 의 임기는 2.5 년입니다. 총 연간 보상은 $ 1.51M, 49.8% 로 구성됩니다. 49.8% 급여 및 50.2% 보너스(회사 주식 및 옵션 포함). 는 $ 2.63M 가치에 해당하는 회사 주식의 0.46% 직접 소유합니다. 2.63M. 경영진과 이사회의 평균 재임 기간은 각각 1.5 년과 3.3 년입니다.

주요 정보

Patrick Blair

최고 경영자

US$1.5m

총 보상

CEO 급여 비율	49.8%
CEO 임기	2.5yrs
CEO 소유권	0.5%
경영진 평균 재임 기간	1.5yrs
이사회 평균 재임 기간	3.3yrs

최근 관리 업데이트

Recent updates

InnovAge Holding Corp.'s (NASDAQ:INNV) Shares Leap 30% Yet They're Still Not Telling The Full Story

Jun 28

InnovAge Holding Corp.'s (NASDAQ:INNV) Intrinsic Value Is Potentially 73% Above Its Share Price

Aug 10

Cautious Investors Not Rewarding InnovAge Holding Corp.'s (NASDAQ:INNV) Performance Completely

Jun 08

InnovAge GAAP EPS of -$0.09 misses by $0.06, revenue of $172.86M misses by $1.11M

Sep 13

InnovAge names Richard Feifer as chief medical officer

Aug 17

InnovAge Holding (NASDAQ:INNV) Could Be Struggling To Allocate Capital

Jul 27

Earnings Miss: InnovAge Holding Corp. Missed EPS And Analysts Are Revising Their Forecasts

May 12

Here's What's Concerning About InnovAge Holding's (NASDAQ:INNV) Returns On Capital

Apr 14

Is There An Opportunity With InnovAge Holding Corp.'s (NASDAQ:INNV) 30% Undervaluation?

Mar 24

InnovAge Pursues Compliance As Precursor To Post-Pandemic Growth

Mar 19

InnovAge Holding's (NASDAQ:INNV) Robust Earnings Are Supported By Other Strong Factors

Nov 16

Are Investors Undervaluing InnovAge Holding Corp. (NASDAQ:INNV) By 48%?

Jul 28

CEO 보상 분석

Patrick Blair 의 보수는 InnovAge Holding 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Mar 31 2024	n/a	n/a	-US$31m
Dec 31 2023	n/a	n/a	-US$32m
Sep 30 2023	n/a	n/a	-US$38m
Jun 30 2023	US$2m	US$750k	-US$41m
Mar 31 2023	n/a	n/a	-US$42m
Dec 31 2022	n/a	n/a	-US$38m
Sep 30 2022	n/a	n/a	-US$27m
Jun 30 2022	US$8m	US$438k	-US$7m

보상 대 시장: Patrick 의 총 보상 ($USD 1.51M ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 2.46M ).

보상과 수익: Patrick 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Patrick Blair (53 yo)

2.5yrs

테뉴어

US$1,506,600

보상

Mr. Patrick Blair serves as President of InnovAge Holding Corp. since December 1, 2021 and as its CEO since January 01, 2022. He had been the Chief Marketing Officer and Senior Vice President of Commercial...

리더십 팀

이름	위치	테뉴어	보상	소유권
Patrick Blair	President & CEO	2.5yrs	US$1.51m	0.46% $ 3.1m
Nicole D'Amato	Chief Legal Officer & Corporate Secretary	2.9yrs	US$1.48m	0.042% $ 282.2k
Richard Feifer	Chief Medical Officer	1.8yrs	US$1.39m	0.022% $ 151.2k
Edward Kennedy	Independent Director	no data	US$100.00k	0.017% $ 114.1k
Marilyn Tavenner	Independent Director	no data	US$120.00k	데이터 없음
Benjamin Adams	Chief Financial Officer	less than a year	데이터 없음	데이터 없음
Christine Bent	Chief Operations Officer	1.3yrs	데이터 없음	0.019% $ 128.2k
Cara Babachicos	Chief Information Officer	1.3yrs	데이터 없음	데이터 없음
Ryan Kubota	Director of Investor Relations	no data	데이터 없음	데이터 없음
Olivia Patton	Chief Compliance Officer	no data	데이터 없음	데이터 없음
Matt Huray	Chief Strategy & Corporate Development Officer	less than a year	데이터 없음	데이터 없음
Rob Borella	Chief Sales & Marketing Officer	1.8yrs	데이터 없음	데이터 없음

1.5yrs

평균 재임 기간

57yo

평균 연령

경험이 풍부한 관리: INNV 의 관리팀은 경험 (평균 재직 기간 1.5 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Edward Kennedy	Independent Director	3.3yrs	US$100.00k	0.017% $ 114.1k
Marilyn Tavenner	Independent Director	3.3yrs	US$120.00k	데이터 없음
Andrew Cavanna	Director	3.3yrs	데이터 없음	데이터 없음
James Carlson	Independent Non-Executive Chairman	2yrs	US$200.00k	0.021% $ 141.6k
Thomas Scully	Director	3.3yrs	데이터 없음	0.074% $ 496.0k
Richard Zoretic	Independent Director	3.3yrs	US$120.00k	데이터 없음
John Bush	Independent Director	3.3yrs	US$100.00k	데이터 없음
Teresa Sparks	Independent Director	less than a year	데이터 없음	데이터 없음
Patricia Fontneau	Independent Director	1.3yrs	US$125.00k	데이터 없음

3.3yrs

평균 재임 기간

63yo

평균 연령

경험이 풍부한 이사회: INNV 의 이사회는 경험(평균 재직 기간 3.3 년)으로 간주됩니다.

InnovAge Holding 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

InnovAge Holding Corp. Appoints John Koehn as Senior Vice President of External Affairs

InnovAge Holding Corp., Annual General Meeting, Dec 13, 2023

Innovage Holding Corp. Names Darlene Flaig as New Chief Nursing Officer

InnovAge Holding Corp. Announces the Appointment of Teresa Sparks to Its Board of Directors

InnovAge Holding Corp. Announces CFO Changes

High number of new and inexperienced directors

Recent updates

InnovAge Holding Corp.'s (NASDAQ:INNV) Shares Leap 30% Yet They're Still Not Telling The Full Story

InnovAge Holding Corp. (NasdaqGS:INNV) announces an Equity Buyback for $5 million worth of its shares.

New minor risk - Share price stability

InnovAge Holding Corp. Appoints John Koehn as Senior Vice President of External Affairs

Price target decreased by 12% to US$6.00

InnovAge Holding Corp. Reiterates Financial Guidance for the Full Fiscal Year 2024

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Sentiment Still Eluding InnovAge Holding Corp. (NASDAQ:INNV)

InnovAge Holding Corp. to Report Q3, 2024 Results on May 07, 2024

InnovAge Holding (NASDAQ:INNV) Has Debt But No Earnings; Should You Worry?

Price target decreased by 9.3% to US$6.50

Consensus EPS estimates fall by 18%

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

InnovAge Holding Corp. Provides Earnings Guidance for the Full Fiscal Year 2024

InnovAge Holding Corp. to Report Q2, 2024 Results on Feb 06, 2024

Market Still Lacking Some Conviction On InnovAge Holding Corp. (NASDAQ:INNV)

Consensus EPS estimates fall by 113%

Consensus EPS estimates fall by 127%, revenue upgraded

First quarter 2024 earnings: EPS misses analyst expectations

InnovAge Holding Corp., Annual General Meeting, Dec 13, 2023

InnovAge Holding Corp. to Report Q1, 2024 Results on Nov 07, 2023

Innovage Holding Corp. Names Darlene Flaig as New Chief Nursing Officer

Consensus EPS estimates fall by 60%

Price target decreased by 8.3% to US$7.33

InnovAge Holding Corp. Provides Full Fiscal Year 2024 Financial Guidance

Full year 2023 earnings: EPS misses analyst expectations

InnovAge Holding Corp. to Report Q4, 2023 Results on Sep 12, 2023

InnovAge Holding Corp. Announces the Appointment of Teresa Sparks to Its Board of Directors

InnovAge Holding Corp.'s (NASDAQ:INNV) Intrinsic Value Is Potentially 73% Above Its Share Price

Now 21% undervalued

InnovAge Holding Corp. Announces CFO Changes

Now 20% undervalued after recent price drop

InnovAge Holding Corp.(NasdaqGS:INNV) dropped from Russell Small Cap Comp Value Index

Cautious Investors Not Rewarding InnovAge Holding Corp.'s (NASDAQ:INNV) Performance Completely

Now 24% undervalued after recent price drop

Third quarter 2023 earnings: EPS misses analyst expectations

Consensus EPS estimates upgraded to US$0.24 loss

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

InnovAge Holding Corp. to Report Q2, 2023 Results on Feb 07, 2023

Price target increased to US$7.00

High number of new and inexperienced directors

InnovAge Holding Corp., Annual General Meeting, Dec 13, 2022

InnovAge Holding Corp. to Report Q1, 2023 Results on Nov 08, 2022

InnovAge Holding Corp. Not Provides Earnings Guidance for the Fiscal Year 2023

Investor sentiment improved over the past week

InnovAge GAAP EPS of -$0.09 misses by $0.06, revenue of $172.86M misses by $1.11M

InnovAge Holding Corp. to Report Q4, 2022 Results on Sep 13, 2022

InnovAge Holding Corp. Appoints Kathy Andreasen as Chief People Officer

InnovAge Holding Corp. Names Richard Feifer as Chief Medical Officer

InnovAge names Richard Feifer as chief medical officer

InnovAge Holding (NASDAQ:INNV) Could Be Struggling To Allocate Capital

InnovAge Appoints James Carlson to Its Board of Directors and as Non-Executive Chairman

Investor sentiment deteriorated over the past week

Consensus forecasts updated

Price target decreased to US$4.70

Earnings Miss: InnovAge Holding Corp. Missed EPS And Analysts Are Revising Their Forecasts

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Here's What's Concerning About InnovAge Holding's (NASDAQ:INNV) Returns On Capital

Is There An Opportunity With InnovAge Holding Corp.'s (NASDAQ:INNV) 30% Undervaluation?

Price target decreased to US$5.00

Less than half of directors are independent

InnovAge Pursues Compliance As Precursor To Post-Pandemic Growth

Kaskela Law LLC Announces Class Action Lawsuit Against Innovage Holding Corp. and Encourages Long-Term Investors to Contact the Firm

InnovAge Holding Corp. to Report Q2, 2022 Results on Feb 09, 2022

InnovAge Holding Corp. Withdraws Fiscal Year 2022 Guidance

Investor sentiment deteriorated over the past week

InnovAge Holding's (NASDAQ:INNV) Robust Earnings Are Supported By Other Strong Factors

First quarter 2022 earnings released: EPS US$0.057 (vs US$0.15 loss in 1Q 2021)